Author

Sanket Koul

Articles

Parl panel raps Health Ministry over SSDRS funding gaps, approval delays

Panel flags funding discontinuity in drug regulation scheme, urges swift SSDRS 2.0 approval and decentralisation of medical device clearances to ease bottlenecks and improve oversight

Read Article

Dr Reddy's enters semaglutide market, launches diabetes generic drug

Drugmaker expects to receive regulatory approval for weightloss sema generic in a few months

Read Article

Centre proposes doing away with double testing of blood plasma products

Union Health Ministry moves to remove repeated HIV, Hepatitis tests on pooled plasma to align with global norms and ease compliance while maintaining patient safety

Read Article

Centre plans national assessment of district hospitals for emergency care

The Centre will conduct a nationwide assessment of district hospitals to identify gaps in emergency and trauma care infrastructure and strengthen facilities in line with IPHS norms

Read Article

Centre to roll out free HPV vaccine drive for 14-year-old girls nationwide

India will launch a nationwide, free and voluntary HPV vaccination campaign for 14-year-old girls, using Gardasil under strict quality norms, as part of efforts to eliminate cervical cancer

Read Article

RBI allowing direct bank lending to REITs may speed up asset expansion

Industry executives note that REITs raise debt by issuing securities subscribed to by mutual funds and non-banking financial companies (NBFCs)

Read Article

Centre mandates drug cos to submit post-approval changes for new drugs

Draft amendment seeks mandatory reporting of manufacturing and quality changes to drug regulator

Read Article

Health Ministry targets 30 mn hospitalisations under PMJAY for FY27

The health ministry is targeting a sharp rise in hospital admissions and claims disbursal under PMJAY in FY27, even as the Budget provides only a marginal increase in the scheme's overall allocation

Read Article

FM announces ₹10,000 crore scheme to promote biopharma manufacturing

Finance Minister Nirmala Sitharaman announced Mission Biopharma Shakti in the Budget, a five-year ₹10,000 crore programme to build domestic capabilities in biologics, biosimilars and clinical research

Read Article

Centre halves review period for applications to conduct new drug trials

The health ministry has amended the NDCT Rules to cut approval timelines for new drug trials and testing by half, aiming to speed up innovation while easing regulatory processes for most applications

Read Article